All Resources

This page provides filters and search facilities across all types of CF resources contained within the ECFS website.

Additionally, you can visit the specific resource type pages as follows:

More information on CF publications can be found here: Publications

June 2020

Title: A disruption of innervation around CF tissues results in low amount of VIP before CF disease has produced damage to the lungs and small intestine.
References
J Cyst Fibros. 2020 Jun 26;S1569-1993(20)30777-3. doi: 10.1016/j.jcf.2020.06.013. Online ahead of print

June 2020

Title: Fibrocyte accumulation in the lungs of cystic fibrosis patients
References
J Cyst Fibros. 2020 Jun 24;S1569-1993(20)30756-6. doi: 10.1016/j.jcf.2020.06.011. Online ahead of print.

June 2020

Title: Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events
References
J Cyst Fibros. 2020 Jun 23;S1569-1993(20)30730-X. doi: 10.1016/j.jcf.2020.06.001.
Title: Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
References
J Cyst Fibros. 2020 Jun 23;S1569-1993(20)30752-9. doi: 10.1016/j.jcf.2020.06.012. Online ahead of print.

June 2020

Title: Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis
References
J Cyst Fibros. 2020 Jun 22;S1569-1993(20)30779-7. doi: 10.1016/j.jcf.2020.06.015. Online ahead of print

June 2020

Title: Influenza B outbreak at an adult cystic fibrosis centre - clinical impact and factors influencing spread
References
J Cyst Fibros. 2020 Jun 19;S1569-1993(20)30124-7. doi: 10.1016/j.jcf.2020.04.011.

June 2020

Title: In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells
References
J Cyst Fibros. 2020 Jun 18;S1569-1993(20)30151-X. doi: 10.1016/j.jcf.2020.05.007. Online ahead of print.

June 2020

Title: Antimicrobial resistance: concerns of healthcare providers and people with CF
References
J Cyst Fibros . 2020 Jun 17;S1569-1993(20)30159-4. doi: 10.1016/j.jcf.2020.05.009

June 2020

Title: Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging
References
J Cyst Fibros. 2020 Jun 16;S1569-1993(20)30733-5. doi: 10.1016/j.jcf.2020.06.004.

June 2020

Title: Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis
References
J Cyst Fibros . 2020 Jun 13;S1569-1993(20)30731-1. doi: 10.1016/j.jcf.2020.06.002. 
Title: The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
References
J Cyst Fibros. 2020 Jun 13;S1569-1993(20)30163-6. doi: 10.1016/j.jcf.2020.05.013.
Title: Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins
References
J Cyst Fibros. 2020 Jun 13;S1569-1993(20)30754-2. doi: 10.1016/j.jcf.2020.06.009.
Title: Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations
References
J Cyst Fibros . 2020 Jun 13;S1569-1993(20)30128-4. doi: 10.1016/j.jcf.2020.04.015.

June 2020

Title: Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells
References
J Cyst Fibros . 2020 Jun 11;S1569-1993(20)30150-8. doi: 10.1016/j.jcf.2020.05.006. Online ahead of print.
Title: Accumulation and persistence of Ivacaftor in airway epithelia with prolonged treatment
References
J Cyst Fibros . 2020 Jun 11;S1569-1993(20)30123-5. doi: 10.1016/j.jcf.2020.04.010.

June 2020

Title: Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review
References
J Cyst Fibros . 2020 Jun 10;S1569-1993(20)30164-8. doi: 10.1016/j.jcf.2020.05.014.

June 2020

Title: Building global development strategies for cf therapeutics during a transitional cftr modulator era
References
J Cyst Fibros . 2020 Jun 7;S1569-1993(20)30161-2. doi: 10.1016/j.jcf.2020.05.011. Online ahead of print.

June 2020

Title: Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis
References
J Cyst Fibros . 2020 Jun 4;S1569-1993(20)30152-1. doi: 10.1016/j.jcf.2020.05.008

June 2020

Title: Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation
References
J Cyst Fibros. 2020 Jun 1;S1569-1993(20)30127-2. doi: 10.1016/j.jcf.2020.04.014. Online ahead of print.